Glucophage Sr

Indicated to manage blood glucose levels and formulated to support type 2 diabetes treatment.

Strengths: 500mg

Medicine details

Alternative names

Bolamyn SR

Therapeutic class

Biguanide Antidiabetic

Pharmacological class

Biguanide

Known off-label uses

polycystic ovary syndrome

Contraindications

renal failure; diabetic ketoacidosis; hypersensitivity to metformin

Precautions and warnings

monitor kidney function; risk of lactic acidosis in certain patients

Minor side effects

nausea; diarrhoea; abdominal pain

Moderate side effects

taste disturbance; vitamin b12 deficiency

Serious side effects

lactic acidosis — requires immediate medical attention

Dosage forms

Prolonged-release tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Accord

Onset Time

2–4 hours

Duration

12–24 hours

Storage instructions

Store below 25°C.

Drug interactions

alcohol; iodinated contrast media

Age restrictions

Use with caution in elderly patients.

Pregnancy and breastfeeding

Pregnancy: management of diabetes preferred with insulin.

Patient summary

Indicated to manage blood glucose levels and formulated to support type 2 diabetes treatment.

Mechanism of action

Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake.

Glucophage Sr

Indicated to manage blood glucose levels and formulated to support type 2 diabetes treatment.

Editorial Notes

  • Active ingredient(s): Metformin
  • Listed indication(s): Type 2 Diabetes Mellitus

Available option

  • 180 tablets - 500 mg322-500-mg-6196